PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16815566-10	2006	During dobutamine plasma ET-1 and AM showed a great individual variability resulting in no significant difference among groups.	Dobutamine	7-17	endothelin 1	Homo sapiens	25-36	
16815566-12	2006	During dobutamine ET-1 was significantly correlated to Pap/CO characteristics (Slope and ET-1ven, r=-0.59, p<0.05; Slope and ET-1art-ven, r=-0.60, p<0.05; Intercept and ET-1art-ven, r=0.63, p<0.004), and ET-1art-ven was the only independent variable related to Slope and Intercept.	Dobutamine	7-17	endothelin 1	Homo sapiens	18-22	
9884482-0	1998	Changes of endothelin-1 and atrial natriuretic peptide during dobutamine stress echocardiography.	Dobutamine	62-72	endothelin 1	Homo sapiens	11-23	
9884482-1	1998	The aim of this study was to test the hypothesis that plasma endothelin-1 (ET-1) and atrial natriuretic peptide (ANP) concentrations in patients with ischemic heart disease are related either to myocardial ischemia or left ventricular (LV) dysfunction during dobutamine stress echocardiography.	Dobutamine	259-269	endothelin 1	Homo sapiens	61-73	
9884482-11	1998	During peak dobutamine infusion, the ET-1 concentration dropped 8.7% from the baseline in group I, 10.2% in group II, and 10.5% in group III.	Dobutamine	12-22	endothelin 1	Homo sapiens	37-41	
10462014-9	1999	The plasma concentrations of endothelin-1 and 6-keto-prostaglandin F1alpha were significantly increased after DOB stress in the ischemia group, but the serum concentration of NO did not increase.	Dobutamine	110-113	endothelin 1	Homo sapiens	29-41